Gene · 563
Papers1,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tear proteomics in dry eye disease. | Indian J Ophthalmol | 2023 | 37026251 | PubTator, text mining | PubMed |
| Novel bacterial proteolytic and metabolic activity associated with dental erosion-induced oral dysbiosis. | Microbiome | 2023 | 37004076 | PubTator, text mining | PubMed |
| SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128. | Viruses | 2023 | 36992331 | PubTator, text mining | PubMed |
| Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review. | Int J Mol Sci | 2023 | 36982359 | PubTator, text mining | PubMed |
| Extracellular Vesicles: The Future of Diagnosis in Solid Organ Transplantation? | Int J Mol Sci | 2023 | 36982182 | PubTator, text mining | PubMed |
| Conditioned Media from Head and Neck Cancer Cell Lines and Serum Samples from Head and Neck Cancer Patients Drive Catabolic Pathways in Cultured Muscle Cells. | Cancers (Basel) | 2023 | 36980729 | PubTator, text mining | PubMed |
| Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology. | BMC Genomics | 2023 | 36964488 | PubTator, text mining | PubMed |
| Zinc-alpha 2 glycoprotein a diagnostic Biomarker for early stage oral Squamous Cell Carcinoma. | Pak J Med Sci | 2023 | 36950446 | PubTator, text mining | PubMed |
| The molecular consequences of androgen activity in the human breast. | Cell Genom | 2023 | 36950379 | PubTator, text mining | PubMed |
| Proteomic analysis of sialoliths from calcified, lipid and mixed groups as a source of potential biomarkers of deposit formation in the salivary glands. | Clin Proteomics | 2023 | 36949424 | PubTator, text mining | PubMed |
| Transcriptomic profiling and differential analysis reveal the renal toxicity mechanisms of mice under cantharidin exposure. | Toxicol Appl Pharmacol | 2023 | 36907384 | PubTator, text mining | PubMed |
| TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1. | Mol Cell | 2023 | 36898370 | PubTator, text mining | PubMed |
| Antidiabetic effects of Andrographis paniculata supplementation on biochemical parameters, inflammatory responses, and oxidative stress in canine diabetes. | Front Pharmacol | 2023 | 36865924 | PubTator, text mining | PubMed |
| Using biological constraints to improve prediction in precision oncology. | iScience | 2023 | 36852282 | PubTator, text mining | PubMed |
| Potential Early Markers for Breast Cancer: A Proteomic Approach Comparing Saliva and Serum Samples in a Pilot Study. | Int J Mol Sci | 2023 | 36835577 | PubTator, text mining | PubMed |
| LncRNA LINC01094 Promotes Cells Proliferation and Metastasis through the PTEN/AKT Pathway by Targeting AZGP1 in Gastric Cancer. | Cancers (Basel) | 2023 | 36831602 | PubTator, text mining | PubMed |
| Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment. | Curr Issues Mol Biol | 2023 | 36826037 | PubTator, text mining | PubMed |
| Macular Edema in Central Retinal Vein Occlusion Correlates With Aqueous Fibrinogen Alpha Chain. | Invest Ophthalmol Vis Sci | 2023 | 36820679 | PubTator, text mining | PubMed |
| Current progress and critical challenges to overcome in the bioinformatics of mass spectrometry-based metaproteomics. | Comput Struct Biotechnol J | 2023 | 36817962 | PubTator, text mining | PubMed |
| Acute physiological effects following Bacillus subtilis DE111 oral ingestion - a randomised, double blinded, placebo-controlled study. | Benef Microbes | 2023 | 36790091 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/563/papers?page=11